alloxan has been researched along with neuropeptide y in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunn-Meynell, AA; Levin, BE; Sanders, NM | 1 |
| Andersen, ND; Cai, X; Guthrie, P; Logerfo, FW; Malek, J; Martin, M; Pradhan, L; Veves, A; Wu, S | 1 |
2 other study(ies) available for alloxan and neuropeptide y
| Article | Year |
|---|---|
Third ventricular alloxan reversibly impairs glucose counterregulatory responses.
Topics: Alloxan; Animals; Blood Glucose; Eating; Enzyme Inhibitors; Fourth Ventricle; Glucokinase; Glucose; Hyperglycemia; Hypothalamus; Injections; Injections, Intraventricular; Male; Medulla Oblongata; Neuropeptide Y; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Third Ventricle | 2004 |
Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing.
Topics: Alloxan; Animals; Cytokines; Diabetes Mellitus, Experimental; Disease Models, Animal; Inflammation; Interleukin-6; Interleukin-8; Neuropeptide Y; Neuropeptides; Rabbits; Substance P; Wound Healing | 2011 |